Streetwise Reports' Article Archives — December 2018 back to current month (14)

Coverage Initiated on Pharma 'Leveraging Large Markets with Differentiated Products' (12/29/2018)

A Ladenburg Thalmann report outlined the investment thesis for this Colorado-based life sciences firm.


Therapeutics Developer Secures Patents, Continues Phase 3 Trial Planning (12/24/2018)

An H.C. Wainwright & Co. report provided an update on the Q3/18 activities and achievements of this company targeting NASH.


Coverage Initiated on Vaccine Developer with 'Transformational' Data Expected (12/24/2018)

A Ladenburg Thalmann report discussed this biotech's late-stage clinical assets in RSV and influenza.


Analyst: Biopharma Makes 'Right Call' in Stopping Combination Agent in Trial (12/19/2018)

A Mackie Research Capital Corp. note reviewed recent and upcoming developments in this immunotherapy developer's clinical study.


Urgent Update on Canadian Health Company Acquisition (12/18/2018)

Technical analyst Clive Maund charts the potentially transformative acquisition of a medical software provider in Canada.


15 Reasons Why Hemp Producer Elixinol Should Be in Your Portfolio (12/17/2018)

With the U.S. government legalizing hemp in the recently passed 2018 Farm Bill, Fincom Investment Partners profiles a hemp company whose largest market is the U.S.


Small-Cap Firm Announces Major Medical Technology Acquisition (12/17/2018)

Ron Struthers of Struthers Resource Stock Report profiles an innovative medical firm in Canada that just announced the acquisition of a medical technology firm, a move that will expand its reach across Canada.


Telehealth Services Provider's Positive Q3/18 Results Reflect 'Robust Growth Rate' (12/12/2018)

A William Blair report reviewed the firm's operational and financial numbers for the period.


Coverage Initiated on Tech Firm Servicing Healthcare Industry (12/12/2018)

Haywood Securities presented the thesis for investment in this company, including its growth drivers and continued focus on acquisition.


Strong Health Stock 'Ready to Commence New Upleg' (12/11/2018)

Technical analyst Clive Maund analyzes a rapidly expanding company with medical clinics in British Columbia that is using advanced technology and AI.


Health Stock 'Looking Set to Bounce Back After 90% Drop' (12/11/2018)

Technical analyst Clive Maund charts a telemedicine technology company and explains why he believes the company's stock should rebound.


Small-Cap Company Could Be the Face of the Future of Medicine (12/10/2018)

A company in Canada that is changing the paradigm for providing healthcare in Canada and potentially elsewhere by integrating technology and artificial intelligence has just announced a major acquisition.


Biotech Delivers Positive Study Results for Prostate Cancer Prognostic Test (12/05/2018)

An H.C. Wainwright & Co. report reviewed this firm's latest news concerning a data readout, trial approval and therapeutic application.


Precision Medicine Developer Secures Another Patent for Drug Candidate (12/05/2018)

This company takes a step forward in its efforts to protect its intellectual property.


More Archives

2024Jun May Apr Mar Feb Jan

2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes